490 BioTech receives NIH Phase II SBIR award for improving drug discovery screens and 3D microphysiological assays
September 21, 2019
490 BioTech is pleased to announce the acquisition of a Phase II SBIR award from the National Institutes of Health, National Institute of General Medical Sciences for the development of new high-throughput drug discovery screens